Section Arrow
Quote
AXGN.NASDAQ
- Axogen
Quotes are at least 15-min delayed:2025/02/01 10:20 EST
Last
 18.21
-0.06 (-0.33%)
Day High 
18.74 
Prev. Close
18.27 
1-M High
19.06 
Volume 
218.07K 
Bid
17.6
Ask
18.78
Day Low
18.16 
Open
18.2 
1-M Low
14 
Market Cap 
804.03M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 18.41 
20-SMA 17.55 
50-SMA 15.74 
52-W High 19.06 
52-W Low 5.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.33/0.64
Enterprise Value
871.78M
Balance Sheet
Book Value Per Share
2.26
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
159.01M
Operating Revenue Per Share
3.46
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.9608-0.1292-11.85%-- 
QSIQuantum-Si1.98+0.02+1.02%-- 
PACBPacific Biosciences of California1.54-0.06-3.75%-- 
MDTMedtronic plc90.82-1.17-1.27%28.13PE
ABTAbbott Laboratories127.93-0.88-0.68%39.2PE
Quotes are at least 15-min delayed：2025/02/01 10:20 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.